Scientific and technological advances achieved with industrial expansion have led to an ever-increasing demand for heavy metals. This demand has, in turn, led to increased contamination of soil, water and air with these metals. Chronic exposure to metals may be detrimental not only to occupational workers but also to the nonoccupational population exposed to these metals. Manganese (Mn), a commonly used heavy metal, is an essential cofactor for many enzymatic processes that drive biological functions. However, it is also a potential source of neurotoxicity, particularly in the field of movement disorders. The typical manifestation of Mn overexposure is parkinsonism, which may be difficult to differentiate from the more common idiopathic Parkinson’s disease. In addition to environmental exposure to Mn, other potential etiologies causing hypermanganesemia include systemic health conditions, total parenteral nutrition and genetic mutations causing Mn dyshomeostasis. In this review, we critically analyze Mn and discuss its sources of exposure, pathophysiology and clinical manifestations. We have highlighted the global public health impact of Mn and emphasize that movement disorder specialists should record a detailed social and occupational history to ensure that a toxic etiology is not misdiagnosed as a neurodegenerative disease. In the absence of a definite therapeutic option, early diagnosis and timely institution of preventive measures are the keys to managing its toxic effects.
Citations
Citations to this article as recorded by
The cGAS−STING-mediated ROS and ferroptosis are involved in manganese neurotoxicity Zhimin Zhang, Jirui Yang, Qiongli Zhou, Shiyin Zhong, Jingjing Liu, Xin Zhang, Xuhong Chang, Hui Wang Journal of Environmental Sciences.2025; 152: 71. CrossRef
The potential hazards of smoking pots: Quantification of the black paint on the ceramics in the Atacama Desert Bernardo Arriaza, Siân Halcrow, Arnoldo Vizcarra, Sebastián Gutiérrez, Juan Pablo Ogalde, Vivien Standen, Mariela Santos Journal of Archaeological Science: Reports.2025; 61: 104955. CrossRef
Investigation of Heavy Metal Analysis on Medicinal Plants Used for the Treatment of Skin Cancer by Traditional Practitioners in Pretoria Oluwaseun Mary Oladeji, Boikanyo Genneyrolter Kopaopa, Liziwe Lizbeth Mugivhisa, Joshua Oluwole Olowoyo Biological Trace Element Research.2024; 202(2): 778. CrossRef
Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) Cells Catherine M. Cahill, Sanjan S. Sarang, Rachit Bakshi, Ning Xia, Debomoy K. Lahiri, Jack T. Rogers Biomolecules.2024; 14(6): 647. CrossRef
Update: Protective and risk factors for Parkinson disease Nikolas Grotewold, Roger L. Albin Parkinsonism & Related Disorders.2024; 125: 107026. CrossRef
Sex-specific associations of a ferroalloy metal mixture with motor function in Italian adolescents Alexa Friedman, Samantha Schildroth, Victoria Fruh, Maxine H. Krengel, Yorghos Tripodis, Donatella Placidi, Roberta F. White, Roberto G. Lucchini, Donald R. Smith, Robert O. Wright, Megan K. Horton, Birgit Claus Henn Environmental Epidemiology.2024; 8(4): e321. CrossRef
Early Onset Parkinsonism: Differential diagnosis and what not to miss Norlinah Mohamed Ibrahim, Chin Hsien Lin Parkinsonism & Related Disorders.2024; 129: 107100. CrossRef
Dopaminergic REST/NRSF is protective against manganese-induced neurotoxicity in mice Edward Pajarillo, Sanghoon Kim, Alexis Digman, Itunu Ajayi, Ivan Nyarko-Danquah, Deok-Soo Son, Michael Aschner, Eunsook Lee Journal of Biological Chemistry.2024; : 107707. CrossRef
Secondary parkinsonism associated with focal brain lesions Rok Berlot, Anđela Pavlović, Maja Kojović Frontiers in Neurology.2024;[Epub] CrossRef
Magnetic Hyperthermia in Glioblastoma Multiforme Treatment Veronica Manescu (Paltanea), Iulian Antoniac, Gheorghe Paltanea, Iosif Vasile Nemoianu, Aurel George Mohan, Aurora Antoniac, Julietta V. Rau, Stefan Alexandru Laptoiu, Petruta Mihai, Horia Gavrila, Abdel Rahim Al-Moushaly, Alin Danut Bodog International Journal of Molecular Sciences.2024; 25(18): 10065. CrossRef
Vitaminlerin ve Metallerin Çift Yönlü Etkileri: Sağlık, Mutajenite ve Antimutajenite Üzerine Bir İnceleme Eda Delik, Burcu Emine Tefon Öztürk, Bülent Kaya Environmental Toxicology and Ecology.2024; 4(2): 73. CrossRef
Effect of fish-heavy metals contamination on the generation of reactive oxygen species and its implications on human health: a review Yuxia Wang, Anwar Noman, Chao Zhang, Wedad Q. AL-Bukhaiti, Sherif M. Abed Frontiers in Marine Science.2024;[Epub] CrossRef
The Regulation of ZIP8 by Dietary Manganese in Mice Suetmui Yu, Ningning Zhao International Journal of Molecular Sciences.2023; 24(6): 5962. CrossRef
Manganese Neurotoxicity as a Stroke Mimic: A Case Report Mohiudeen Alikunju, Nafeesathu Misiriyyah , Shaikh Sayeed Iqbal, Maria Khan Cureus.2023;[Epub] CrossRef
Associations of ambient manganese exposure with brain gray matter thickness and white matter hyperintensities Shinyoung Woo, Young Noh, Sang-Baek Koh, Seung-Koo Lee, Jung il Lee, Ho Hyun Kim, Sun- Young Kim, Jaelim Cho, Changsoo Kim Hypertension Research.2023; 46(8): 1870. CrossRef
The Role of Oxidative Stress in Manganese Neurotoxicity: A Literature Review Focused on Contributions Made by Professor Michael Aschner David C. Dorman Biomolecules.2023; 13(8): 1176. CrossRef
Small noncoding RNA dysregulation is implicated in manganism in a rat model of methylcyclopentadienyl manganese tricarbonyl-induced unrepaired striatum damage Qifeng Zhu, Fan Jiang, Yuanbo Song, Lili Lu, Fajian He, Shuqi Huang, Zhaoying Huang, Jing Yao, Ningning Lei, Jianmin Huang, Shijin Lu The Journal of Toxicological Sciences.2023; 48(10): 535. CrossRef
Trace Elements Open a New Direction for the Diagnosis of Atherosclerosis Heyu Meng, Jianjun Ruan, Yanqiu Chen, Zhaohan Yan, Jinsha Liu, Xue Wang, Xin Meng, Jingru Wang, Qiang Zhang, Xiangdong Li, Fanbo Meng Reviews in Cardiovascular Medicine.2023;[Epub] CrossRef
Differentiating Wild and Apiary Honey by Elemental Profiling: a Case Study from Mangroves of Indian Sundarban Tanushree Gaine, Praveen Tudu, Somdeep Ghosh, Shouvik Mahanty, Madhurima Bakshi, Nabanita Naskar, Souparna Chakrabarty, Subarna Bhattacharya, Swati Gupta Bhattacharya, Kashinath Bhattacharya, Punarbasu Chaudhuri Biological Trace Element Research.2022; 200(10): 4550. CrossRef
Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review Efthalia Angelopoulou, Yam Nath Paudel, Sokratis G. Papageorgiou, Christina Piperi Brain Sciences.2022; 12(2): 175. CrossRef
Ayahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects Ľuboš Nižnanský, Žofia Nižnanská, Roman Kuruc, Andrea Szórádová, Ján Šikuta, Anežka Zummerová Journal of Clinical Medicine.2022; 11(4): 1147. CrossRef
Can therapeutic plasma exchange be life-saving in life-threatening manganese intoxication? Emel Uyar, Esra Gurkas, Aysel Unlusoy Aksu, Serhat Emeksiz, Cigdem Seher Kasapkara, Nadide Basak Gulleroglu, Ikbal Ok Bozkaya, Kader Karlı Oguz Transfusion and Apheresis Science.2022; 61(4): 103417. CrossRef
Manganese‐induced parkinsonism responsive to intranasal insulin: A case report Mehri Salari, Masoud Etemadifar, Leila Dargahi, Neda Valian, Malihe Rezaee Clinical Case Reports.2022;[Epub] CrossRef
The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease Adrianne F. Pike, Ildikò Szabò, Robert Veerhuis, Luigi Bubacco npj Parkinson's Disease.2022;[Epub] CrossRef
Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene Jae-Hyeok Lee, Jin-Hong Shin Journal of Movement Disorders.2022; 15(2): 171. CrossRef
Manganese chloride (MnCl2) induced novel model of Parkinson’s disease in adult Zebrafish; Involvement of oxidative stress, neuroinflammation and apoptosis pathway Abhishek.P.R. Nadig, Bader Huwaimel, Ahmed Alobaida, El-Sayed Khafagy, Hadil Faris Alotaibi, Afrasim Moin, Amr Selim Abu Lila, Suman, Sahyadri. M, K.L. Krishna Biomedicine & Pharmacotherapy.2022; 155: 113697. CrossRef
Çalışma Yaşamında Manganez Maruz Kalımının Sağlık Etkileri ve Parkinsonizm Zehra GÖK METİN, Abdulsamet SANDAL, Ali Naci YILDIZ Karaelmas İş Sağlığı ve Güvenliği Dergisi.2021; 5(2): 147. CrossRef
Typically, progressive supranuclear palsy (PSP) is clinically characterized by slow vertical saccades or supranuclear gaze palsy, levodopa-resistant parkinsonism with predominant axial symptoms, and cognitive executive impairment. Over the past decades, various PSP phenotypes, including PSP with predominant parkinsonism, PSP with corticobasal syndrome, PSP with progressive gait freezing, and PSP with predominant frontal dysfunction, have been identified from pathologically confirmed cases. Expanding knowledge led to new diagnostic criteria for PSP that with increased disease awareness led to increased PSP prevalence estimates. The identification of environmental and modifiable risk factors creates an opportunity to intervene and delay the onset of PSP or slow disease progression. To date, despite the increasing number of publications assessing risk factors for PSP, few articles have focused on environmental and lifestyle risk factors for this disorder. In this article, we reviewed the literature investigating the relationship between PSP and several environmental and other modifiable lifestyle risk factors. In our review, we found that exposures to toxins related to diet, metals, well water, and hypertension were associated with increased PSP risk. In contrast, higher education and statins may be protective. Further case-control studies are encouraged to determine the exact role of these factors in the etiopathogenesis of PSP, which in turn would inform strategies to prevent and reduce the burden of PSP.
Citations
Citations to this article as recorded by
Parkinson’s Disease is Predominantly a Genetic Disease Shen-Yang Lim, Christine Klein Journal of Parkinson’s Disease.2024; 14(3): 467. CrossRef
Progressive supranuclear palsy, a case report A. Ortiz, F. Troya, J. de Vera, E. Vázquez Archivos de la Sociedad Española de Oftalmología (English Edition).2024; 99(7): 304. CrossRef
Progressive Supranuclear Palsy Syndrome: An Overview Eduardo Ichikawa-Escamilla, Rodrigo A. Velasco-Martínez, Laura Adalid-Peralta IBRO Neuroscience Reports.2024; 16: 598. CrossRef
The Role of MicroRNAs in Progressive Supranuclear Palsy—A Systematic Review Aleksandra Ćwiklińska, Grzegorz Procyk, Dariusz Koziorowski, Stanisław Szlufik International Journal of Molecular Sciences.2024; 25(15): 8243. CrossRef
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid Yura Jang, Sungtaek Oh, Anna J. Hall, Zhen Zhang, Thomas F. Tropea, Alice Chen-Plotkin, Liana S. Rosenthal, Ted M. Dawson, Chan Hyun Na, Alexander Y. Pantelyat Clinical Proteomics.2024;[Epub] CrossRef
The Effect of Alcohol Consumption on Progressive Supranuclear Palsy: A Cross‐Sectional Study Min Tian, Bohan Zhang, Heyin Liu, Yinlian Han, Mu Yang, Ruonan Duan, Dandan Guo, Chengyuan Song, Jun Ma, Yiming Liu CNS Neuroscience & Therapeutics.2024;[Epub] CrossRef
Progressive supranuclear palsy’s economical burden: the use and costs of healthcare resources in a large health provider in Israel Yael Barer, Raanan Cohen, Meital Grabarnik-John, Xiaolan Ye, Jorge Zamudio, Tanya Gurevich, Gabriel Chodick Journal of Neurology.2023; 270(8): 3770. CrossRef
The Pesticide Chlordecone Promotes Parkinsonism-like Neurodegeneration with Tau Lesions in Midbrain Cultures and C. elegans Worms Valeria Parrales-Macias, Patrick P. Michel, Aurore Tourville, Rita Raisman-Vozari, Stéphane Haïk, Stéphane Hunot, Nicolas Bizat, Annie Lannuzel Cells.2023; 12(9): 1336. CrossRef
The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis Shane Lyons, Dominic Trépel, Tim Lynch, Richard Walsh, Sean O’Dowd Journal of Neurology.2023; 270(9): 4451. CrossRef
Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy Aliz Persely, Beatrix Beszedics, Krisztina Paloczi, Marton Piroska, Amirreza Alijanpourotaghsara, David Strelnikov, Arsalan Vessal, Helga Szabo, Anita Hernyes, Luca Zoldi, Zsofia Jokkel, Andrea Fekete, Janos Juhasz, Nora Makra, Dora Szabo, Edit Buzas, Ada Medicina.2023; 59(10): 1696. CrossRef
Dementia Prevention in Clinical Practice Kellyann Niotis, Kiarra Akiyoshi, Caroline Carlton, Richard Isaacson Seminars in Neurology.2022; 42(05): 525. CrossRef
Progressive Supranuclear Palsy in 2022: recent developments and an eye to the future Shane Lyons, Sean O'Dowd, Richard Walsh, Tim Lynch Advances in Clinical Neuroscience & Rehabilitation.2022;[Epub] CrossRef
Hirayama Disease and Its Management: Experience of a Tertiary Care Center in Eastern India Selvin Prabhakar Vijayan, Christopher Gerber, Anindya Basu, Mona Tiwari, Tosaddeque M. D. Hussain, Jacky Ganguly Indian Spine Journal.2025; 8(1): 26. CrossRef
Teaching Video NeuroImage: Minipolymyoclonus José Marcos Vieira Albuquerque Filho, Pedro Fraiman, Orlando G.P. Barsottini, José Luiz Pedroso, Alulin Tácio Quadros Santos Monteiro Fonseca Neurology.2025;[Epub] CrossRef
Polyminimyoclonus in Hirayama Disease Samantha A. Banks, Farwa Ali, Bryan T. Klassen, Michelle J. Clarke, W. Oliver Tobin Neurology.2024;[Epub] CrossRef
Meningeal Dissemination and Drop Metastasis From Glioma Presenting With Non-Epileptic Myoclonus and Minipolymyoclonus Arens Taga, Ian Cheong, Kemar E. Green, Michael D. Kornberg The Neurohospitalist.2024;[Epub] CrossRef
Split hand and minipolymyoclonus in spinocerebellar ataxia type 3: a case report Anli Eki, Atsuhiko Sugiyama, Kazumoto Shibuya, Yuki Nakagawa, Takayuki Ishige, Tomoki Suichi, Ryo Otani, Satoshi Kuwabara BMC Neurology.2024;[Epub] CrossRef
Clinical, Electrodiagnostic, Sonographic, and Radiological Findings of Hirayama Disease: A Report of Two Cases and a Review of the Literature Lisa B Shields, Vasudeva G Iyer, Yi Ping Zhang, Christopher B Shields Cureus.2024;[Epub] CrossRef
Diagnostic Utility of Clinical Neurophysiology in Jerky Movement Disorders: A Review from the MDS Clinical Neurophysiology Study Group Anna Latorre, Christos Ganos, Masashi Hamada, Nicolas Phielipp, Lorenzo Rocchi, Shabbir Merchant, Marina A. Tijssen, Sterre van der Veen, Robert Chen Movement Disorders Clinical Practice.2024;[Epub] CrossRef
Functional disorders as a common motor manifestation of COVID‐19 infection or vaccination Wilson K. W. Fung, Qais Sa'di, Hans Katzberg, Robert Chen, Anthony E. Lang, Angela M. Cheung, Alfonso Fasano European Journal of Neurology.2023; 30(3): 678. CrossRef
Peripherally-induced Movement Disorders: An Update Abhishek Lenka, Joseph Jankovic Tremor and Other Hyperkinetic Movements.2023;[Epub] CrossRef
Finger trembling improvement after surgery in Hirayama disease: a case report Nobuaki Tadokoro, Kyuichi Hashimoto, Katsuhito Kiyasu, Yusuke Kasai, Naoki Aoyama, Ryuichi Takemasa, Masahiko Ikeuchi Spinal Cord Series and Cases.2022;[Epub] CrossRef
Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ‐1 Mutation Stephen G. Reich, Karan Desai, Shruti Agrawal, Priyanka Walzade, Sangeeta Ravat, Pankaj A. Agarwal, Alberto J. Espay Movement Disorders Clinical Practice.2021;[Epub] CrossRef
Polyminimyoclonus in Hirayama disease Dylan Meng, Kimia Ghavami, Tychicus Chen BMJ Case Reports.2021; 14(10): e246831. CrossRef
Objective Telemedicine has rapidly gained momentum in movement disorder neurology during the coronavirus disease (COVID-19) pandemic to preserve clinical care while mitigating the risks of in-person visits. We present data from the rapid implementation of virtual visits in a large, academic, movement disorder practice during the COVID-19 pandemic.
Methods We describe the strategic shift to virtual visits and retrospectively examine elements that impacted the ability to switch to telemedicine visits using historical prepandemic in-person data as a comparator, including demographics, distance driven, and diagnosis distribution, with an additional focus on patients with deep brain stimulators.
Results A total of 686 telemedicine visits were performed over a five-week period (60% of those previously scheduled for in-office visits). The average age of participants was 65 years, 45% were female, and 73% were Caucasian. Men were more likely to make the transition (p = 0.02). Telemedicine patients lived farther from the clinic than those seen in person (66.47 km vs. 42.16 km, p < 0.001), age was not associated with making the switch, and patient satisfaction did not change. There was a significant shift in the distribution of movement disorder diagnoses seen by telemedicine compared to prepandemic in-person visits (p < 0.001). Patients with deep brain stimulators were more likely to use telemedicine (11.5% vs. 7%, p < 0.001).
Conclusion Telemedicine is feasible, viable and relevant in the care of movement disorder patients, although health care disparities appear evident for women and minorities. Patients with deep brain stimulators preferred telemedicine in our study. Further study is warranted to explore these findings.
Citations
Citations to this article as recorded by
Interest and Satisfaction of Telemedicine Use Among Ambulatory Neurology Patients in Western North Carolina During the COVID-19 Pandemic K. Alexander Soltany, Reyna Segovia Molina, Carly Pappo, Sharon Thomson, Kelly Pring, Siobhan Cox, Rebecca Merrill, Emily Fishman, Alexander Ambrosini, Gabby Bognet, Kristen Dodenhoff, Heidi Munger Clary, Lauren Strauss, Rachel Graham, Amy K. Guzik, Roy E Telemedicine and e-Health.2024; 30(4): e1071. CrossRef
The Importance of Digital Health Literacy in an Evolving Parkinson’s Disease Care System Christine D. Esper, Blanca Y. Valdovinos, Ruth B. Schneider, Elke Kalbe, Bastiaan R. Bloem, Lorraine V. Kalia, Alice Nieuwboer Journal of Parkinson’s Disease.2024; 14(s1): S181. CrossRef
Neurological Examination via Telemedicine: An Updated Review Focusing on Movement Disorders Efthalia Angelopoulou, Christos Koros, Evangelia Stanitsa, Ioannis Stamelos, Dionysia Kontaxopoulou, Stella Fragkiadaki, John D. Papatriantafyllou, Evangelia Smaragdaki, Kalliopi Vourou, Dimosthenis Pavlou, Panagiotis D. Bamidis, Leonidas Stefanis, Sokrat Medicina.2024; 60(6): 958. CrossRef
Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives Andreas Wolfgang Wolff, Bernhard Haller, Antonia Franziska Demleitner, Dominik Pürner, Johanna Niederschweiberer, Isabell Cordts, Erica Westenberg, Paul Lingor Movement Disorders Clinical Practice.2023; 10(5): 819. CrossRef
Telemedicine technologies and applications in the era of COVID-19 pandemic: A systematic review Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Mohammad Heydari, Amirali Karimi, Abdollah Mahdavi, Mehrnaz Mashoufi, Arezoo Sarmad, Peyman Mirghaderi, Ahmadreza Shamsabadi, Kowsar Qaderi, Pegah Mirzapour, Amirata Fakhfouri, Hadiseh Azadi Cheshmekabodi, Kimia Health Informatics Journal.2023;[Epub] CrossRef
Racial disparities in access to DBS: results of a real-world U.S. claims data analysis Michael Frassica, Drew S. Kern, Mitra Afshari, Allison T. Connolly, Chengyuan Wu, Nathan Rowland, Juan Ramirez-Castaneda, Mwiza Ushe, Claudia Salazar, Xenos Mason Frontiers in Neurology.2023;[Epub] CrossRef
Parkinson’s disease patients’ perspective on telephone visits during the COVID-19 pandemic Marta Magriço, Miguel Serôdio, Rita Ventura, Paulo Bugalho Journal of Neural Transmission.2023; 130(12): 1547. CrossRef
Telemedicine in Neurology: A Scoping Review of Key Outcomes in Movement Disorders Emily Houston, Amanda G. Kennedy, Donna O'Malley, Terry Rabinowitz, Gail L. Rose, James Boyd Telemedicine and e-Health.2022; 28(3): 295. CrossRef
Clinician and patient experience of neurology telephone consultations during the COVID-19 pandemic Tagore Nakornchai, Elena Conci, Anke Hensiek, J William L Brown Postgraduate Medical Journal.2022; 98(1161): 533. CrossRef
Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research B. Y. Valdovinos, J. S. Modica, R. B. Schneider Current Neurology and Neuroscience Reports.2022; 22(2): 113. CrossRef
Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 Pandemic Shadi Ghourchian, Yasar A. Torres-Yaghi, Stuart H. Isaacson, Fernando Pagan, Kelly E. Lyons, Brian James Nagle, Sanskruti Patel, Rajesh Pahwa Telemedicine and e-Health.2022; 28(11): 1651. CrossRef
Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study Yaqian Xu, Megan P. Feeney, Matthew Surface, Dan Novak, Michelle S. Troche, James C. Beck, Roy N. Alcalay Movement Disorders.2022; 37(6): 1289. CrossRef
Service process factors affecting patients’ and clinicians’ experiences on rapid teleconsultation implementation in out-patient neurology services during COVID-19 pandemic: a scoping review Guangxia Meng, Carrie McAiney, Christopher M. Perlman, Ian McKillop, Therese Tisseverasinghe, Helen H. Chen BMC Health Services Research.2022;[Epub] CrossRef
Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives Esther Cubo, Pedro David Delgado-López Brain Sciences.2022; 12(12): 1735. CrossRef
Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey Rimal Bera, Morgan Bron, Betsy Benning, Samantha Cicero, Heintje Calara, Diane Darling, Ericha Franey, Kendra Martello, Charles Yonan Neuropsychiatric Disease and Treatment.2022; Volume 18: 2945. CrossRef
Objective There is limited literature on the knowledge, attitude, and perceptions (KAP) of botulinum toxin (BoNT) treatment among patients and caregivers. The objective of this study was to assess the KAP in patients undergoing BoNT treatment for movement disorders.
Methods One hundred patients with movement disorders from National Institute of Mental Health and Neurosciences Hospital in Bengaluru, South India, were recruited. The patients underwent demographic, clinical, and Patient Knowledge Questionnaire on Botulinum Toxin Use in Movement Disorders (PKQ-BMD)-based evaluations.
Results The mean age of patients at the time of presentation was 47.97 ± 14.19 years (range, 12–79). Of all the patients, 26 (28%) patients were anxious, and 86% of these patients were reassured after appropriate counseling. There were 83 (89%) patients who found BoNT to be a costlier option. Education and previous Internet searches influenced positive performance in the “knowledge” domain and overall PKQ-BMD scores. The “number of injections” was also positively correlated with KAP performance.
Conclusion This study showed that knowledge and perceptions about BoNT treatment need to be further improved. Wider availability of the Internet has provided a positive impact on patients’ and carers’ KAP. Internet-based information, higher educational qualifications of the patients, and a higher number of BoNT injection sessions are the most important predictors of satisfactory KAP related to BoNT injection treatment in patients with movement disorders.
Objective
Medication beliefs are a significant determinant of medication adherence in chronic illness. This study aimed to identify demographic, clinical, and medication-related factors associated with medication beliefs in patients with Parkinson’s disease (PD).
Methods
We used a descriptive cross-sectional design with a convenience sample of 173 PD patients who had been taking antiparkinson drugs for more than one year.
Results
The subjects who believed PD medication was more necessary had more severe illness, younger age of onset, longer illness duration, and longer duration of levodopa therapy. They had higher levels of non-motor symptoms and depression, number of medication uses, number of drugs, and levodopa equivalent dose, and they reported fluctuation of motor symptoms and dyskinesia. The subjects who used catechol-O-methyltransferase (COMT) inhibitors, dopamine agonists, amantadine, and monoamine oxidase-B (MAO-B) inhibitors had significantly higher necessity scores than those who did not use them. The subjects who had higher concerns about PD medications had higher levels of non-motor symptoms and depression. The subjects using amantadine and anticholinergics had significantly higher concern scores than those who did not use them. Positive necessity-concerns differentials were associated with severe illness, the presence of motor fluctuation and dyskinesia, and the use of COMT inhibitors. Based on stepwise multiple regression, the most significant factors influencing necessity beliefs were severe illness, followed by depression and motor fluctuation.
Conclusion
Severe illness, higher levels of depression, and motor fluctuation are independent factors influencing patients’ beliefs regarding medication necessity. Therefore, these characteristics should be considered in medication belief assessment and interventions for PD patients.
Citations
Citations to this article as recorded by
Adherence to Parkinson's disease medication: A case study to illustrate reasons for non-adherence, implications for practice and engaging under-represented participants in research Delyth James, Joshua Smith, Emma Lane, Rhian Thomas, Sarah Brown, Heidi Seage Exploratory Research in Clinical and Social Pharmacy.2024; 14: 100450. CrossRef
Relationship Between Medication Literacy and Beliefs Among Persons with Type 2 Diabetes Mellitus in Guangdong, China Sifen Jiang, Zhuoqi Zhu, Guisheng Liao, Yanling Huang, Lichang Li, Kun Zeng Patient Preference and Adherence.2023; Volume 17: 2039. CrossRef
Effect of Pillbox Organizers with Alarms on Adherence to Pharmacotherapy in Parkinson Disease Patients Taking Three and More Daily Doses of Dopaminergic Medications Igor Straka, Michal Minar, Milan Grofik, Matej Skorvanek, Veronika Bolekova, Andrea Gazova, Jan Kyselovic, Peter Valkovic Journal of Personalized Medicine.2022; 12(2): 179. CrossRef
Factors Related to Beliefs about Medication in Ischemic Stroke Patients Gye-Gyoung Kim, Sung-Hee Yoo, Man-Seok Park, Hyun-Young Park, Jae-Kwan Cha Journal of Clinical Medicine.2022; 11(13): 3825. CrossRef
Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson’s disease Jiangbo Song, Lian Liu, Zhiquan Li, Ting Mao, Jianfei Zhang, Lei Zhou, Xin Chen, Yunzhu Shang, Tao Sun, Yuxin Luo, Yu Jiang, Duan Tan, Xiaoling Tong, Fangyin Dai BMC Medicine.2022;[Epub] CrossRef
Objective
To evaluate the accuracy and quality of Korean videos associated with restless legs syndrome (RLS) on YouTube.
Methods
A YouTube search was performed on April 1, 2020 using the term “restless legs syndrome” in the Korean language. Two reviewers coded the source, content, and demographics of the included videos. Video quality was assessed using the modified DISCERN (mDISCERN) instrument.
Results
Among the 80 videos analyzed, 44 (55.0%) were reliable, and 36 (45.0%) were misleading. There was a trend toward a higher number of mean daily views in the misleading videos than in the reliable videos. Most of the misleading videos (72.2%) advocated complementary and alternative medicine as a primary treatment for RLS. Although the reliable videos had higher mDISCERN scores than the misleading videos, the overall quality of the reliable videos was low.
Conclusion
Many Korean videos regarding RLS on YouTube involve a risk of exposure to misinformation and are of unsatisfactory quality.
Citations
Citations to this article as recorded by
Quality and reliability of YouTube videos as a source of information on pulmonary rehabilitation Aytül COŞAR ERTEM, Uğur ERTEM The European Research Journal.2023; 9(5): 992. CrossRef
The portrayal of hearing loss information in online Mandarin videos Chandan H. Suresh, Kiara Leng, Nilesh J. Washnik, Satyabrata Parida Journal of Otology.2023; 18(3): 152. CrossRef
YouTube as an information source for pulmonary rehabilitation in patients with COVID-19: A Cross-Sectional Study Çağlar KARABAŞ, Yıldız Gonca DOĞRU Genel Tıp Dergisi.2022; 32(3): 259. CrossRef
Objective To determine the volume changes in gray and white matter during a long-term follow-up in patients suffering from pantothenate kinase-associated neurodegeneration (PKAN).
Methods Magnetic resonance imaging was repeated in 13 patients and 14 age-matched controls after a mean interval of more than 7 years. T1-weighted sequences were evaluated by fully automated atlas-based volumetry, compared between groups and correlated with disease progression.
Results The patients did not show generalized cerebral atrophy but did show a significantly faster volume reduction in the globus pallidus during follow-up (between -0.96% and -1.02% per year, p < 0.05 adjusted for false discovery rate) than controls, which was significantly related to the progression in their dystonia scores (p = 0.032).
Conclusion The volume loss in the globus pallidus over time—together with the accumulation of iron known as the “tiger’s eye”—supports the pathophysiologic concept of this nucleus as a center of inhibition and its severe malfunction in PKAN.
Citations
Citations to this article as recorded by
Pantothenate Kinase Activation Restores Brain Coenzyme A in a Mouse Model of Pantothenate Kinase-Associated Neurodegeneration Chitra Subramanian, Matthew W. Frank, Rajaa Sukhun, Christopher E. Henry, Anna Wade, Mallory E. Harden, Satish Rao, Rajendra Tangallapally, Mi-Kyung Yun, Stephen W. White, Richard E. Lee, Uma Sinha, Charles O. Rock, Suzanne Jackowski The Journal of Pharmacology and Experimental Therapeutics.2024; 388(1): 171. CrossRef
Neurodegeneration with iron accumulation in the brain, peculiarities of course and approach to treatment Т.A. Dovbonos, V.O. Svystilnyk, V.Yu. Krylova, G.G. Simonenko INTERNATIONAL NEUROLOGICAL JOURNAL.2024; 20(7): 375. CrossRef
Cerebral and cerebellar white matter tract alterations in patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) Diones Rivera, Pedro Roa-Sanchez, Pamela Bidó, Herwin Speckter, Jairo Oviedo, Peter Stoeter Parkinsonism & Related Disorders.2022; 98: 1. CrossRef
Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy Nicola Romano, Giammarco Baiardi, Valeria Maria Pinto, Sabrina Quintino, Barbara Gianesin, Riccardo Sasso, Andrea Diociasi, Francesca Mattioli, Roberta Marchese, Giovanni Abbruzzese, Antonio Castaldi, Gian Luca Forni Journal of Clinical Medicine.2022; 11(15): 4524. CrossRef
Neurological manifestations of coronavirus disease (COVID-19) have increasingly been reported since the onset of the pandemic. Herein, we report a relatively new presentation. A patient in the convalescence period following a febrile illness with lower respiratory tract infection (fever, myalgia, nonproductive cough) presented with generalized disabling myoclonus, which is phenotypically suggestive of brainstem origin, along with additional truncal cerebellar ataxia. His neurology work-ups, such as brain MRI, electroencephalography, serum autoimmune and paraneoplastic antibody testing, were normal. His CT chest scan revealed right lower lung infiltrates, and serological and other laboratory testing did not show evidence of active infection. COVID-19 titers turned out to be strongly positive, suggestive of post-COVID-19 lung sequelae. He responded partially to antimyoclonic drugs and fully to a course of steroids, suggesting a para- or postinfectious immune-mediated pathophysiology. Myoclonusataxia syndrome appears to be a neurological manifestation of COVID-19 infection, and knowledge regarding this phenomenon should be increased among clinicians for better patient care in a pandemic situation.
Citations
Citations to this article as recorded by
A case of suspected autoimmune encephalopathy with involuntary movements and cognitive dysfunction post‐COVID‐19 Yosuke Tenpaku, Naoki Mabuchi, Takahiro Kawase, Hideki Oguro, Hiroshi Tatsumi, Masayuki Satoh Psychiatry and Clinical Neurosciences Reports.2024;[Epub] CrossRef
Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2 Josef Finsterer, Fulvio A. Scorza Neuro-Ophthalmology.2023; 47(1): 1. CrossRef
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid Isa Lindqvist, Janet L. Cunningham, Jan Mulder, Amalia Feresiadou, Elham Rostami, Johan Virhammar, Eva Kumlien European Journal of Neurology.2023; 30(10): 3142. CrossRef
Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19 Kenta Osawa, Atsuhiko Sugiyama, Akiyuki Uzawa, Shigeki Hirano, Tatsuya Yamamoto, Masahiko Nezu, Nobuyuki Araki, Hiroki Kano, Satoshi Kuwabara Internal Medicine.2022; 61(7): 1071. CrossRef
Post‐infectious cerebellar ataxia following COVID‐19 in a patient with epilepsy Sidhartha Chattopadhyay, Judhajit Sengupta, Sagar Basu Clinical and Experimental Neuroimmunology.2022; 13(4): 323. CrossRef
Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis Rizaldy Taslim Pinzon, Vincent Ongko Wijaya, Abraham Al Jody, Patrick Nalla Nunsio, Ranbebasa Bijak Buana Journal of Infection and Public Health.2022; 15(8): 856. CrossRef
Anti-neuronal antibodies against brainstem antigens are associated with COVID-19 Guglielmo Lucchese, Antje Vogelgesang, Fabian Boesl, Dina Raafat, Silva Holtfreter, Barbara M. Bröker, Angela Stufano, Robert Fleischmann, Harald Prüss, Christiana Franke, Agnes Flöel eBioMedicine.2022; 83: 104211. CrossRef
Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins Massimiliano Godani, Alessandro Beronio, Giuseppe Lanza Movement Disorders Clinical Practice.2022;[Epub] CrossRef
Spectrum of de novo movement disorders in the setting of COVID-19 infection Mitesh Chandarana, Heli Shah, Soaham Desai Annals of Movement Disorders.2022; 5(1): 23. CrossRef
Anti-GAD associated post-infectious cerebellitis after COVID-19 infection Ahmed Serkan Emekli, Asuman Parlak, Nejla Yılmaz Göcen, Murat Kürtüncü Neurological Sciences.2021; 42(10): 3995. CrossRef
The POLG gene encodes mitochondrial DNA polymerase, and mutations in this gene cause a spectrum of disorders related to mitochondrial DNA depletion or deletion. Dystonia has only rarely been reported as an early and prominent manifestation of POLG mutations. We report a case of a 30-year-old male presenting with lower limb dystonia with peripheral neuropathy and demonstrate that the dystonia was levodopa responsive (with video findings). Whole-genome sequencing revealed biallelic variants in the POLG gene: a known pathogenic variant [NM_001126131.2:c.2209G>C (p.Gly737Arg)] and a novel likely pathogenic variant [NM_001126131.2:c.3305A>C (p.Gln1102Pro)]. A genetic diagnosis was made before the appearance of more readily recognizable features of mitochondrial disease, allowing us to avoid invasive tissue biopsies or potentially deleterious treatments, such as sodium valproate. A POLG-related disorder should be suspected in cases of dystonia with peripheral neuropathy, and this diagnosis may have implications for further investigations and management.
Citations
Citations to this article as recorded by
Presentation, Treatment, and Outcome of a First Stroke-like Episode in a Carrier of the Compound Heterozygous Variants c.695G_A and c.2209G_C in POLG: A Case Report Dominik Zieglgänsberger, Josef Finsterer Cureus.2025;[Epub] CrossRef
Genome sequencing reanalysis increases the diagnostic yield in dystonia Avi Fellner, Gurusidheshwar M. Wali, Neil Mahant, Bianca R. Grosz, Melina Ellis, Ramesh K. Narayanan, Karl Ng, Ryan L. Davis, Michel C. Tchan, Katya Kotschet, Dennis Yeow, Laura I. Rudaks, Sue-Faye Siow, Gautam Wali, Con Yiannikas, Matthew Hobbs, Joseph C Parkinsonism & Related Disorders.2024; 124: 107010. CrossRef
Possible EIF2AK2‐Associated Stress‐Related Neurological Decompensation with Combined Dystonia and Striatal Lesions Sophie E. Waller, Hugo Morales‐Briceño, Laura Williams, Shekeeb S. Mohammad, Avi Fellner, Kishore R. Kumar, Michel Tchan, Victor S.C. Fung Movement Disorders Clinical Practice.2022; 9(2): 240. CrossRef
Movement disorders and neuropathies: overlaps and mimics in clinical practice Francesco Gentile, Alessandro Bertini, Alberto Priori, Tommaso Bocci Journal of Neurology.2022; 269(9): 4646. CrossRef
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia Damiana Scuteri, Kengo Hamamura, Chizuko Watanabe, Paolo Tonin, Giacinto Bagetta, Maria Tiziana Corasaniti International Journal of Molecular Sciences.2022; 23(15): 8580. CrossRef
An overview of the pharmacotherapeutics for dystonia: advances over the past decade O. Abu-hadid, J. Jimenez-Shahed Expert Opinion on Pharmacotherapy.2022; 23(17): 1927. CrossRef
Exploitation of Thermal Sensitivity and Hyperalgesia in a Mouse Model of Dystonia Damiana Scuteri, Laura Rombolà, Silvia Natoli, Antonio Pisani, Paola Bonsi, Kengo Hamamura, Giacinto Bagetta, Paolo Tonin, Maria Tiziana Corasaniti Life.2021; 11(9): 985. CrossRef
Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases Theresa Kraft, Konrad Grützmann, Matthias Meinhardt, Friedegund Meier, Dana Westphal, Michael Seifert Scientific Reports.2023;[Epub] CrossRef
A TNR Frameshift Variant in Weimaraner Dogs with an Exercise‐Induced Paroxysmal Movement Disorder Matthias Christen, Rodrigo Gutierrez‐Quintana, Matthew James, Kiterie M.E. Faller, Mark Lowrie, Clare Rusbridge, Kenny Bossens, Cathryn Mellersh, Louise Pettitt, Tiina Heinonen, Hannes Lohi, Vidhya Jagannathan, Tosso Leeb Movement Disorders.2023; 38(6): 1094. CrossRef
Tenascin‐R Autoimmunity: Isolated Tremor Reversed with Immunotherapy Binxia Yang, Andrew Brown, Andrew McKeon, J. Eric Ahlskog, Philip Tipton, Yong Guo, Claudia Lucchinetti, Sean J. Pittock, Anastasia Zekeridou Annals of Neurology.2023; 94(3): 502. CrossRef
Whole-Genome Study of a Multigenerational Family with Essential Tremor Ming Zhang, Mohammad Rohani, Mahdi Montazer Haghighi, Christine Sato, Ekaterina Rogaeva, Alfonso Fasano Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2022; 49(3): 381. CrossRef
Predicting Parkinson disease related genes based on PyFeat and gradient boosted decision tree Marwa Helmy, Eman Eldaydamony, Nagham Mekky, Mohammed Elmogy, Hassan Soliman Scientific Reports.2022;[Epub] CrossRef